These observations support the findings that low NCoR expression is associated with invasive breast tumors [27, 28], a shorter relapse-free survival [29] and resistance to anti-estrogen treatment [30], suggesting the role of NCoR as a tumor suppressor. Here, NCOR1 is linked to neoplasm.